<html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<style type="text/css">
.txt { white-space:nowrap; }
#f0 { font-family:sans-serif; font-weight:normal; font-style:normal; }
#f1 { font-family:sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff3; src: url("3.ttf"); }
#f2 { font-family:ff3,sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff0; src: url("0.ttf"); }
#f3 { font-family:ff0,sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff2; src: url("2.ttf"); }
#f4 { font-family:ff2,sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff1; src: url("1.ttf"); }
#f5 { font-family:ff1,sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff4; src: url("4.ttf"); }
#f6 { font-family:ff4,sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff8; src: url("8.ttf"); }
#f7 { font-family:ff8,sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff9; src: url("9.ttf"); }
#f8 { font-family:ff9,sans-serif; font-weight:normal; font-style:normal; }
</style>
</head>
<body>
<img id="background" style="position:absolute; left:0px; top:0px;" width="595" height="841" src="page2.png">
<div class="txt" style="position:absolute; left:466px; top:54px;"><span id="f2" style="font-size:8px;vertical-align:baseline;color:rgba(255,255,255,1);">셀트리온</span><span id="f3" style="font-size:8px;vertical-align:baseline;color:rgba(255,255,255,1);">(068270)</span></div>
<div class="txt" style="position:absolute; left:193px; top:93px;"><span id="f3" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">[</span><span id="f2" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">그림 </span><span id="f3" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">1] </span><span id="f2" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">셀트리온그룹 파이프라인</span></div>
<div class="txt" style="position:absolute; left:245px; top:124px;"><span id="f5" style="font-size:10px;vertical-align:baseline;color:rgba(0,0,0,1);">글로벌 경쟁력 강화를 위한 다양한 파이프라인</span></div>
<div class="txt" style="position:absolute; left:346px; top:168px;"><span id="f4" style="font-size:25px;vertical-align:baseline;color:rgba(255,255,255,1);">2</span></div>
<div class="txt" style="position:absolute; left:340px; top:198px;"><span id="f2" style="font-size:8px;vertical-align:baseline;color:rgba(255,255,255,1);">임상 중</span></div>
<div class="txt" style="position:absolute; left:401px; top:159px;"><span id="f7" style="font-size:5px;vertical-align:baseline;color:rgba(0,0,0,1);">• </span><span id="f3" style="font-size:5px;vertical-align:baseline;color:rgba(0,0,0,1);">CT-P16(bevacizumab </span><span id="f2" style="font-size:5px;vertical-align:baseline;color:rgba(0,0,0,1);">바이오시밀러</span><span id="f3" style="font-size:5px;vertical-align:baseline;color:rgba(0,0,0,1);">)</span></div>
<div class="txt" style="position:absolute; left:413px; top:169px;"><span id="f8" style="font-size:5px;vertical-align:baseline;color:rgba(0,0,0,1);"> </span><span id="f2" style="font-size:5px;vertical-align:baseline;color:rgba(0,0,0,1);">독보적 경험과 브랜드 경쟁력</span></div>
<div class="txt" style="position:absolute; left:413px; top:179px;"><span id="f8" style="font-size:5px;vertical-align:baseline;color:rgba(0,0,0,1);"> </span><span id="f2" style="font-size:5px;vertical-align:baseline;color:rgba(0,0,0,1);">원가 경쟁력</span></div>
<div class="txt" style="position:absolute; left:401px; top:190px;"><span id="f7" style="font-size:5px;vertical-align:baseline;color:rgba(0,0,0,1);">• </span><span id="f3" style="font-size:5px;vertical-align:baseline;color:rgba(0,0,0,1);">CT-P17(adalimumab </span><span id="f2" style="font-size:5px;vertical-align:baseline;color:rgba(0,0,0,1);">바이오시밀러</span><span id="f3" style="font-size:5px;vertical-align:baseline;color:rgba(0,0,0,1);">)</span></div>
<div class="txt" style="position:absolute; left:413px; top:200px;"><span id="f8" style="font-size:5px;vertical-align:baseline;color:rgba(0,0,0,1);"> </span><span id="f2" style="font-size:5px;vertical-align:baseline;color:rgba(0,0,0,1);">고농축 제형</span></div>
<div class="txt" style="position:absolute; left:204px; top:269px;"><span id="f7" style="font-size:5px;vertical-align:baseline;color:rgba(0,0,0,1);">• </span><span id="f2" style="font-size:5px;vertical-align:baseline;color:rgba(0,0,0,1);">자가면역질환</span><span id="f3" style="font-size:5px;vertical-align:baseline;color:rgba(0,0,0,1);">(4)</span></div>
<div class="txt" style="position:absolute; left:204px; top:279px;"><span id="f7" style="font-size:5px;vertical-align:baseline;color:rgba(0,0,0,1);">• </span><span id="f2" style="font-size:5px;vertical-align:baseline;color:rgba(0,0,0,1);">항암제</span><span id="f3" style="font-size:5px;vertical-align:baseline;color:rgba(0,0,0,1);">(1)</span></div>
<div class="txt" style="position:absolute; left:204px; top:289px;"><span id="f7" style="font-size:5px;vertical-align:baseline;color:rgba(0,0,0,1);">• </span><span id="f2" style="font-size:5px;vertical-align:baseline;color:rgba(0,0,0,1);">기타</span><span id="f3" style="font-size:5px;vertical-align:baseline;color:rgba(0,0,0,1);">(3)</span></div>
<div class="txt" style="position:absolute; left:290px; top:265px;"><span id="f4" style="font-size:25px;vertical-align:baseline;color:rgba(255,255,255,1);">8</span></div>
<div class="txt" style="position:absolute; left:281px; top:295px;"><span id="f2" style="font-size:8px;vertical-align:baseline;color:rgba(255,255,255,1);">공정개발</span></div>
<div class="txt" style="position:absolute; left:191px; top:334px;"><span id="f2" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">자료</span><span id="f3" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">: </span><span id="f2" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">셀트리온</span><span id="f3" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">, </span><span id="f2" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">한국투자증권</span></div>
<div class="txt" style="position:absolute; left:395px; top:266px;"><span id="f4" style="font-size:24px;vertical-align:baseline;color:rgba(255,255,255,1);">11</span></div>
<div class="txt" style="position:absolute; left:388px; top:295px;"><span id="f2" style="font-size:8px;vertical-align:baseline;color:rgba(255,255,255,1);">세포주 개발</span></div>
<div class="txt" style="position:absolute; left:458px; top:269px;"><span id="f7" style="font-size:5px;vertical-align:baseline;color:rgba(0,0,0,1);">• </span><span id="f2" style="font-size:5px;vertical-align:baseline;color:rgba(0,0,0,1);">자가면역질환</span><span id="f3" style="font-size:5px;vertical-align:baseline;color:rgba(0,0,0,1);">(4)</span></div>
<div class="txt" style="position:absolute; left:458px; top:279px;"><span id="f7" style="font-size:5px;vertical-align:baseline;color:rgba(0,0,0,1);">• </span><span id="f2" style="font-size:5px;vertical-align:baseline;color:rgba(0,0,0,1);">항암제</span><span id="f3" style="font-size:5px;vertical-align:baseline;color:rgba(0,0,0,1);">(5)</span></div>
<div class="txt" style="position:absolute; left:458px; top:289px;"><span id="f7" style="font-size:5px;vertical-align:baseline;color:rgba(0,0,0,1);">• </span><span id="f2" style="font-size:5px;vertical-align:baseline;color:rgba(0,0,0,1);">기타</span><span id="f3" style="font-size:5px;vertical-align:baseline;color:rgba(0,0,0,1);">(2)</span></div>
<div class="txt" style="position:absolute; left:191px; top:384px;"><span id="f5" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">기업개요 및 용어해설</span></div>
<div class="txt" style="position:absolute; left:191px; top:401px;"><span id="f3" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">1991</span><span id="f2" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">년 설립되어 </span><span id="f3" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">2005</span><span id="f2" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">년 코스닥시장에 상장된 후 </span><span id="f3" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">2018</span><span id="f2" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">년 거래소로 이전상장됨</span><span id="f3" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">. </span><span id="f2" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">단백질 의약품의 연구</span><span id="f3" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">, </span><span id="f2" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">개발 및 제조를</span></div>
<div class="txt" style="position:absolute; left:191px; top:413px;"><span id="f2" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">주요 사업으로 영위하고 있음</span><span id="f3" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">. </span><span id="f2" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">대주주는 셀트리온홀딩스로 셀트리온의 </span><span id="f3" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">20% </span><span id="f2" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">지분을 보유하고 있으며 주요 연결자회사로</span></div>
<div class="txt" style="position:absolute; left:191px; top:425px;"><span id="f2" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">는 셀트리온제약</span><span id="f3" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">(</span><span id="f2" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">지분율 </span><span id="f3" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">55%)</span><span id="f2" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">이 있음</span><span id="f3" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">.</span></div>
<div class="txt" style="position:absolute; left:533px; top:795px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(128,128,128,1);">2</span></div>
</body>
</html>
